Found 11 matching trials
Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma PHASE3 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Universitair Medisch Centrum St. Radboud - Nijmegen
Learn More & Join Trial
Timing of Post-prostatectomy PSMA Imaging PHASE2 The investigators will randomize patients presenting with early BCR with a ...
Show More Location
Princess Margaret Cancer Center
Learn More & Join Trial
Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or Refractory N/A PET-based consolidation and donor-based therapy after rescue in patients wi...
Show More Location
Istituto di Ematologia e Oncologia Medica, Policlinico S. Orsola
Learn More & Join Trial
Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes NA The current standard treatment for advanced Hodgkin's lymphoma 6-8 cycles o...
Show More Location
Department of Medical Oncology, Cancer Institute (WIA), Adyar
Learn More & Join Trial
High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients PHASE2 The purpose of this study is to define an improvement in patients:
* To ev...
Show More Location
Centro di riferimento Oncologico Oncologia Medica A
Learn More & Join Trial
Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy PHASE3 All men following Radical Prostatectomy (RP) at NYU Langone Health undergo ...
Show More Status
Active Not Recruiting
Location
Smilow Comprehensive Prostate Cancer Center
Learn More & Join Trial
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer PHASE3 The main purpose of this study is to determine if the addition of apalutami...
Show More Status
Active Not Recruiting
Location
Arizona Urology Specialists
Learn More & Join Trial
Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma PHASE2 The aim of this trial is to develop an effective and well-tolerated regimen...
Show More Location
1st Department of Medicine, Cologne University Hospital
Learn More & Join Trial
BRENTUXIMAB VEDOTIN as Pre-ASCT Induction Therapy in R/R HL Patients Non Responding to IGEV PHASE2 A pilot phase II study with brentuximab vedotin as pre-ASCT induction thera...
Show More Location
Istituto di Ematologia "L. & A. Seragnoli" , Policlinico S. Orsola Malpighi
Learn More & Join Trial
Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL PHASE3 All study treatments have proven efficacy in the treatment in Hodgkin lymph...
Show More Learn More & Join Trial